According to Harvard Bioscience's latest financial reports the company's current earnings are S$97.73 Million. In 2023 the company made an earning of -S$3.48 Million, an increase over its 2022 earnings that were of -S$12.5 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -S$17.71 Million | 408.9% |
2023 | -S$3.48 Million | -72.15% |
2022 | -S$12.5 Million | 6456.43% |
2021 | -S$0.2 Million | -98.08% |
2020 | -S$9.93 Million | 32.53% |
2019 | -S$7.49 Million | -31.01% |
2018 | -S$10.86 Million | 243.9% |
2017 | -S$3.16 Million | -24.66% |
2016 | -S$4.2 Million | -14.69% |
2015 | -S$4.92 Million | -181.68% |
2014 | S$6.01 M | -9.97% |
2013 | S$6.67 M | 120% |
2012 | S$3.03 M | -50.9% |
2011 | S$6.18 M | -52.51% |
2010 | S$13.01 M | -2.53% |
2009 | S$13.35 M | 28.26% |
2008 | S$10.41 M | -20.05% |
2007 | S$13.02 M | 13.96% |
2006 | S$11.42 M | 17.59% |
2005 | S$9.71 M | 57.37% |
2004 | S$6.17 M | -37.31% |
2003 | S$9.85 M | 208.03% |
2002 | S$3.19 M | -168.71% |
2001 | -S$4.66 Million | -66.89% |
2000 | -S$14.06 Million |